This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Paul T. Vaitkus, MD; Howard C. Herrmann, MD; Martin M. LeWinter, MD

JAMA. 1994;272(1):59-64.

Abstract
Objective.
—To discuss the diagnosis and treatment of malignant pericardial Objective.—To fusion and focus on quantitating the success and complication rates of the many treatment modalities and updating recent advances in the field.

Data Sources.
—English-language publications were identified by a computerized search (MEDLINE) of these key words: cancer, tumor, malignancy, pericardium, and pericardial effusion. This computerized search was supplemented by a manual search of the bibliographies of original research articles and textbooks.

Study Selection.
—Studies were included if the outcome of patients undergoing treatment for malignant pericardial effusion was reported separately from the outcome of patients with other causes of pericardial effusions. Studies that only reported the combined results of patients with malignant and nonmalignant effusions were excluded.

Data Extraction.
—To determine success rates for the various treatment modalities, we examined freedom from symptomatic recurrence of pericardial effusion requiring reintervention as the key end point. Where appropriate, we also examined procedural mortality rates.

Results.
—Initial relief of symptoms is achieved in most cases with percutaneous pericardiocentesis that, with echocardiographic guidance, can be performed with low morbidity and mortality. In many cases, drainage for several days with an indwelling catheter alleviates the effusion without subsequent recurrence. Systemic antitumor therapy with chemotherapy or radiation therapy is effective in controlling malignant effusions in cases of sensitive tumors such as lymphomas, leukemias, and breast cancer. Local sclerotherapy with tetracycline hydrochloride or bleomycin sulfate is also effective and associated with low morbidity. Sclerotherapy with other agents or radionuclides offers no advantages. Of the several surgical options, subxiphoid pericardiotomy has the advantage of low morbidity and mortality, can often be performed under local anesthesia, and is highly effective in preventing recurrence. Percutaneous balloon pericardiotomy has recently been described. This intervention is performed with local anesthesia, is effective in preventing reaccumulation, and has a low morbidity.

Conclusions.
—Treatment of malignant pericardial effusions must be individualized with consideration given to the patient's condition and tumor type, the success rates and risks of the various modalities, and local availability and expertise.

(JAMA. 1994;272:59-64)

Author Affiliations
From the Cardiology Unit, Medical Center Hospital of Vermont, University of Vermont, Burlington (Drs Vaitkus and LeWinter), and the Cardiovascular Division, Hospital of the University of Pennsylvania, Philadelphia (Dr Herrmann).

Footnotes
Reprint requests to Cardiology Unit, 1 McClure, Medical Center Hospital of Vermont, University of Vermont, 111 Colchester Ave, Burlington, VT 05401 (Dr Vaitkus).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

CHAPTER 19 Pericardial Disease
Soler-Soler and Sagristà-Sauleda
ESC Textbook of Cardiovascular Medicine 2009;2:med-9780199566990-chapter-med-9780199566990-chapter.
ABSTRACT | FULL TEXT  

Acute dyspnoea, dysphagia, and non-specific chest pain in a smoker
Som et al.
BMJ 2008;337:a2678-a2678.
FULL TEXT  

Pericardial disease: what the general cardiologist needs to know
Ivens et al.
Heart 2007;93:993-1000.
FULL TEXT  

Cardiac metastases
Bussani et al.
J. Clin. Pathol. 2007;60:27-34.
ABSTRACT | FULL TEXT  

Video-Assisted Thoracoscopic Pericardial Window for Diagnosis and Management of Pericardial Effusions
Georghiou et al.
Ann. Thorac. Surg. 2005;80:607-610.
ABSTRACT | FULL TEXT  

Abnormal Cytology Predicts Poor Prognosis in Cancer Patients With Pericardial Effusion
Gornik et al.
JCO 2005;23:5211-5216.
ABSTRACT | FULL TEXT  

Management of Malignant Pericardial Effusion with Instillation of Mitomycin C in Non-small Cell Lung Cancer
Kaira et al.
Jpn J Clin Oncol 2005;35:57-60.
ABSTRACT | FULL TEXT  

Long-term Results of Intrapericardial Chemotherapeutic Treatment of Malignant Pericardial Effusions With Thiotepa
Martinoni et al.
Chest 2004;126:1412-1416.
ABSTRACT | FULL TEXT  

Guidelines on the Diagnosis and Management of Pericardial Diseases Executive Summary: The Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology
Task Force members et al.
Eur Heart J 2004;25:587-610.
FULL TEXT  

Prognostic Factors in the Surgical Management of Pericardial Effusion in the Patient With Concurrent Malignancy
Cullinane et al.
Chest 2004;125:1328-1334.
ABSTRACT | FULL TEXT  

Metastases to the heart
Reynen et al.
Ann Oncol 2004;15:375-381.
FULL TEXT  

Comparison of open subxiphoid pericardial drainage with percutaneous catheter drainage for symptomatic pericardial effusion
McDonald et al.
Ann. Thorac. Surg. 2003;76:811-816.
ABSTRACT | FULL TEXT  

Pericardiocentesis with extended catheter drainage: an effective therapy
Buchanan et al.
Ann. Thorac. Surg. 2003;76:817-820.
ABSTRACT | FULL TEXT  

Technical and Prognostic Outcomes of Double-Balloon Pericardiotomy for Large Malignancy-Related Pericardial Effusions*
Wang et al.
Chest 2002;122:893-899.
ABSTRACT | FULL TEXT  

Consecutive 1127 Therapeutic Echocardiographically Guided Pericardiocenteses: Clinical Profile, Practice Patterns, and Outcomes Spanning 21 Years
Tsang et al.
Mayo Clin Proc. 2002;77:429-436.
ABSTRACT  

GENERAL CARDIOLOGY: Management of pericardial effusion
Soler-Soler et al.
Heart 2001;86:235-240.
FULL TEXT  

Percutaneous Balloon Pericardiotomy for Patients with Malignant Pericardial Effusion Including Three Malignant Pleural Mesotheliomas
Ovunc et al.
ANGIOLOGY 2001;52:323-329.
ABSTRACT  

Management of pericardial effusion by drainage: a survey of 10 years' experience in a city centre general hospital serving a multiracial population
Gibbs et al.
Postgrad. Med. J. 2000;76:809-813.
ABSTRACT | FULL TEXT  

Prognostic Role of Pericardial Fluid Cytology in Cardiac Tamponade Associated With Non-small Cell Lung Cancer
Wang et al.
Chest 2000;118:744-749.
ABSTRACT | FULL TEXT  

Video-assisted thoracoscopic pericardial fenestration for loculated or recurrent effusions
Geissbuhler et al.
Eur. J. Cardiothorac. Surg. 1999;14:403-408.
ABSTRACT | FULL TEXT  

Pericardoscopy for primary management of pericardial effusion in cancer patients
Porte et al.
Eur. J. Cardiothorac. Surg. 1999;16:287-291.
ABSTRACT | FULL TEXT  

Transatrial Access to the Normal Pericardial Space : A Novel Approach for Diagnostic Sampling, Pericardiocentesis, and Therapeutic Interventions
Verrier et al.
Circulation 1998;98:2331-2333.
ABSTRACT | FULL TEXT  

Rescue echocardiographically guided pericardiocentesis for cardiac perforation complicating catheter-based procedures: The Mayo Clinic experience
Tsang et al.
J Am Coll Cardiol 1998;32:1345-1350.
ABSTRACT | FULL TEXT  

Pericardiocentesis and Intrapericardial Sclerosis: Effective Therapy for Malignant Pericardial Effusions
Girardi et al.
Ann. Thorac. Surg. 1997;64:1422-1427.
ABSTRACT | FULL TEXT  

PERICARDIAL SCLEROSIS AS THE PRIMARY MANAGEMENT OF MALIGNANT PERICARDIAL EFFUSION AND CARDIAC TAMPONADE
Maher et al.
J. Thorac. Cardiovasc. Surg. 1996;112:637-643.
ABSTRACT | FULL TEXT